Unit 506 Cocoa Studios

The Biscuit Factory

A salient.bio 100 Drummond
Road
London
SE16 4DG
Certificate of Analysis

Name: Marek Balogh

male
Date of Birth: 30 sep. 1988
Passport Number: HE969768
Sample ID: 845649485746
Date sample taken: 27 May 2022 13:04
Date reported: 27 May 2022 15:06

Test
Type: Nucleic acid amplification test (NAAT).
Method: Quantitative reverse transcription PCR (RT-PCR).
Sample type: Nasopharyngeal swab.
Detail: Test detects RNA (ribonucleic acid) specific to the SARS-CoV-2 virus
using two targets (NI and N2).

Result: Negative
The sample did not contain detectable SARS-CoV-2 viral RNA with either NI or N2
targets. The sample was positive for human material
These results reflect the condition of the individual at the point the sample was taken.
Health status may have changed between the time the sample was taken and the time the
test result was released.

Approved by:
Dr Marta Ciechonska, PhD Virology Dr Miles Priestman, PhD Clinical Medicine
This test is performed by Salient Bio and is pursuant to the CDC EUA testing protocol and recommended by the
WHO. It has been validated against a UKAS-accredited method Salient Bioscience operates according to the ISO
17025 standard Two gene targets are used for detection of SARS—CoV-2 within the gene (t" I and to) which
confirm the presence of viral RNA One gene target for human material (RnaseP) is used as a sample adequacy
control. It is considered the gold standard in terms of accuracy. sensitivity, specificity, and limit of detection.
The test has been extensively validated in-house and is independently assessed through an External Ouality
Assurance program.